ABT's earnings are forecast to grow faster (35.54% per year) than the US Medical Devices industry average (23.54%) 72.75% of the stock of Abbott Laboratories is held by institutions. The ex-dividend date of this dividend is Thursday, January 14th. The company's quarterly revenue was up 2.0% on a year-ove… Abbott Laboratories' management team includes the following people: Buying Tesla Stock? However, solely looking at the historical price movement is usually misleading. Never miss a … Abbott Laboratories has a P/B Ratio of 6.24. The company was founded in 1888 and is headquartered in North Chicago, Illinois. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Do This BEFORE Biden Takes the White House. During the same quarter in the previous year, the firm earned $0.84 EPS. Abbott Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, January 27th 2021. There are currently 1 sell rating, 2 hold ratings and 13 buy ratings for the stock. Abbott Laboratories has a dividend yield of 1.32%, which is in the bottom 25% of all stocks that pay dividends. © 2020 Cable News Network. View analysts' price targets for Abbott Laboratories or view Wall Street analyst' top-rated stocks. Abbott Laboratories has been increasing its dividend for 49 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. ABT Stock Price Forecast for 2021: December 2021: Open: 30439.10: Close: 29665.20: Min: 28948.90: Max: 30440.00: Change: -2.61 % ABT Stock Price Forecast for 2022: January 2022: Open: 29966.80: Close: 30096.90: Min: 29966.80: Max: 30748.50: Change: 0.43 % ABT Stock Price Forecast for 2022: February 2022: Open: 29991.00: Close: 29910.60: Min: 29885.70: Max: 30161.20 MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. This suggests a possible upside of 22.1% from the stock's … View which stocks are hot on social media with MarketBeat's trending stocks report. 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Abbott Laboratories in the last year. Abbott Laboratories has received 839 “outperform” votes. ), Abbott Laboratories has received 689 “underperform” votes. Receive a free world-class investing education from MarketBeat. ABT Stock Forecast - Is ABT a buy or sell? Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. Get short term trading ideas from the MarketBeat Idea Engine. View Abbott Laboratories' earnings history. ABT | Complete Abbott Laboratories stock news by MarketWatch. The consensus among Wall Street research analysts is that investors should "buy" Abbott Laboratories stock. The healthcare product maker earns $3.69 billion in net income (profit) each year or $3.24 on an earnings per share basis. Full-Year 2018 Forecast for ABT Stock Abbott forecast earnings of $2.87 to $2.89 (adjusted), reflecting growth of 15%. ABT Comments Compiled here, all relevant comments and discussions regarding the ABT stock. CNN Sans™ & © 2016 Cable News Network. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Please note that all comments included here have met Investing.com's Comment Guidelines. Its Nutritional Products segment provides pediatric and adult nutritional products. Some companies that are related to Abbott Laboratories include Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), STERIS (STE) and Varian Medical Systems (VAR). Company insiders that have sold Abbott Laboratories company stock in the last year include Andrea F Wainer, Andrew H Lane, Brian B Yoor, Christopher J Scoggins, Daniel Gesua Sive Salvadori, Jared Watkin, John F Ginascol, Joseph J Manning, Lisa D Earnhardt, Mary K Moreland, Michael D Dale, Michael J Pederson, Phebe N Novakovic, Philip P Boudreau, Randel William Woodgrift, Robert E Funck, Roger Bird, and Roxanne S Austin. View Abbott Laboratories' dividend history. Abbott Laboratories has received a consensus rating of Buy. This suggests a possible upside of 4.7% from the stock's current price. (10.00% Upside) Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Is It Too Late to Invest in Coronavirus Test Stocks? The P/E ratio of Abbott Laboratories is 58.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.82. Only 1.70% of the stock of Abbott Laboratories is held by insiders. Abbott (ABT) closed at $109.49 in the latest trading session, marking a +0.97% move from the prior day. 16 Wall Street analysts have issued 1-year price objectives for Abbott Laboratories' stock. Based on earnings estimates, Abbott Laboratories will have a dividend payout ratio of 32.88% next year. Abbott Laboratories' stock was trading at $78.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Wall Street analysts have given Abbott Laboratories a "Buy" rating, but there may be better short-term opportunities in the market. All Rights Reserved. MarketBeat just released five new trading ideas, but Abbott Laboratories wasn't one of them. Looking for new stock ideas? Get daily stock ideas top-performing Wall Street analysts. The P/E ratio of Abbott Laboratories is 58.44, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 30.11. ABT FINANCIAL OTC Stock Forecast is based on your current time horizon. Abbott Laboratories updated its FY 2020 Zacks. Wait Until You See This... With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day. The Abbott … Zacks. View real-time stock prices and stock quotes for a full financial overview. Average Price Target. The 3 Safest Stocks to Buy With Your Stimulus Money. Find the latest Abbott Laboratories (ABT) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Their forecasts range from C$17.00 to C$20.00. Abbott Laboratories has been increasing its dividend for 49 years. To see all exchange delays and terms of use please see disclaimer. Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Scan for strong stocks. This payout ratio is at a healthy, sustainable level, below 75%. The healthcare product maker reported $0.63 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.61 by $0.02. This is a boost from Abbott Laboratories's previous quarterly dividend of $0.36. Investors can use this forecasting interface to forecast Abbott Laboratories historical stock prices and determine the direction of Abbott Laboratories's future trends based on various well-known forecasting models. Their forecasts range from $94.00 to $130.00. Sign-up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Abbott Laboratories (NYSE:ABT) posted its earnings results on Wednesday, April, 17th. All rights reserved. Please log in to your account or sign up in order to add this asset to your watchlist. Pre-Market earnings guidance on Wednesday, October, 21st. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. Top institutional shareholders include Park National Corp OH (0.03%), First Financial Bank Trust Division (0.01%), Rockland Trust Co. (0.00%), Private Trust Co. NA (0.00%), Boltwood Capital Management (0.00%) and Thomasville National Bank (0.00%). Abbott (ABT) Stock Moves -0.23%: What You Should Know. Surprisingly, only roughly 10% of people in the U.S. have made this move... yet it’s already created tens of thousands of millionaires. Frank's International stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for FI in the last 3 months. Abbott Laboratories (NYSE:ABT) announced its earnings results on Wednesday, October, 21st. Benzinga. See what's happening in the market right now with MarketBeat's real-time news feed. Based on aggregate information from My MarketBeat watchlists, some companies that other Abbott Laboratories investors own include AbbVie (ABBV), Johnson & Johnson (JNJ), NVIDIA (NVDA), AT&T (T), Pfizer (PFE), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), The Home Depot (HD) and Verizon Communications (VZ). 2 Perfect Stocks For Low-Risk Investors in 2021, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Factset: FactSet Research Systems Inc.2019. Vote “Underperform” if you believe ABT will underperform the S&P 500 over the long term. View the latest Abbott Laboratories (ABT) stock price, news, historical charts, analyst ratings and financial information from WSJ. This segment also provides glucose and blood glucose monitoring systems. It owes its growth to developments in its medical devices. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. $120.44. On average, they expect Abbott Laboratories' share price to reach $115.69 in the next year. Do Not Sell My Information. The Abbott Laboratories stock price gained 0.97% on the last trading day (Thursday, 31st Dec 2020), rising from $108.44 to $109.49. Abbott Laboratories declared a quarterly dividend on Friday, December 11th. Abbott Laboratories pays an annual dividend of $1.44 per share and currently has a dividend yield of 1.32%. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Find real-time ABT - Abbott Laboratories stock quotes, company profile, news and forecasts from CNN Business. The healthcare product maker earned $7.54 billion during the quarter, compared to analysts' expectations of $7.49 billion. Mar. The dividend payout ratio of Abbott Laboratories is 44.44%. Abbott Laboratories has a PEG Ratio of 2.03. Most stock quote data provided by BATS. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Pitney Bowes (NYSE: PBI) is Surging, Is it Too Risky? Price Target Abbott Laboratories Stock Forecast Over the next 52 weeks, Abbott Laboratories has on average historically risen by 15.6 % based on the past 48 years of stock performance. Here's What Analysts Are Forecasting Next. Abbott Laboratories' stock is owned by many different institutional and retail investors. Find the latest Abbott Laboratories (ABT) stock quote, history, news and other vital information to help you with your stock trading and investing. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. Abbott Laboratories' mailing address is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. © American Consumer News, LLC dba MarketBeat® 2010-2021. From AI system, total return is 1150.37% from 829 forecasts. Identify stocks that meet your criteria using seven unique stock screeners. As a business, ABT is generating more cash flow than 90.62% of positive cash flow stocks in the Healthcare. AC Investment Inc. delivers machine learning based share price forecast. Abbott (ABT) closed at $109.49 in the latest trading session, marking a +0.97% move from the prior day. However, solely looking at the historical price movement is usually misleading. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Abbott Laboratories (ABT) stock price prediction is 173.014942 USD. The healthcare product maker had revenue of $8.85 billion for the quarter, compared to analyst estimates of $8.53 billion. You may vote once every thirty days. ABT stock was sold by a variety of institutional investors in the last quarter, including Park National Corp OH, Rockland Trust Co., Red Spruce Capital LLC, First Financial Bank Trust Division, Private Asset Management Inc., M&R Capital Management Inc., Boltwood Capital Management, and Thomasville National Bank. 17, 2014 - Wed. Nov. 25, 2020) (Abbott Laboratories) With a 5-year investment, the revenue is expected to be around +73.28%. On average, they expect Absolute Software Co. (ABT.TO)'s share price to reach C$18.50 in the next year. View Abbott Laboratories' dividend history. The company provided earnings per share (EPS) guidance of 3.55 for the period, compared to the Thomson Reuters consensus estimate of $3.32. Harley Davidson (NYSE: HOG) Stock Giving Pullback Entries Here, FAT Brands (NASDAQ: FAT) Stock is a Compelling Bargain Buy, It Is Almost Time To Buy More Chewy.com (NYSE:CHWY), 3 Reliable Dividend Stocks to Buy in January, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, View Abbott Laboratories' dividend history, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Abbott (ABT) Outpaces Stock Market Gains: What You Should Know. It will be exciting to see whether it manages to continue gaining or … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Based on earnings estimates, Abbott Laboratories will have a dividend payout ratio of 32.88% next year. Forecast for Dec. 2020 is $106.85, for Nov. 2021 is $116.79, for Nov. 2023 is $106.28, for Nov. 2025 is $70.97, and for Nov. 2030 is $79.1. View insider buying and selling activity for Abbott Laboratories or or view top insider-buying stocks. The business' balance sheet suggests that 9% of the company's capital is sourced from debt; this is greater than only 23.28% of the free cash flow producing stocks we're observing. Abbott Laboratories (ABT:NYQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. All rights reserved. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. ABT Stock Analysis - [Full Report] Free Signup: Advanced stock screener. Abbott Laboratories had a return on equity of 18.19% and a net margin of 10.50%. Learn more. Motley Fool. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.00 between high and low, or 0.00%.For the last week the stock has had daily average volatility of 0.00% View which stocks have been most impacted by COVID-19. Company insiders that own Abbott Laboratories stock include Andrea F Wainer, Andrew H Lane, Brian B Yoor, Brian J Blaser, Christopher J Scoggins, Daniel Gesua Sive Salvadori, Hubert L Allen, Jaime Contreras, Jared Watkin, John F Ginascol, John G Stratton, John M Capek, Joseph J Manning, Lisa D Earnhardt, Mary K Moreland, Michael D Dale, Michael J Pederson, Miles D White, Phebe N Novakovic, Philip P Boudreau, Randel William Woodgrift, Robert E Funck, Roger Bird, Roxanne S Austin, Sally E Blount, Sharon J Bracken and Stephen R Fussell. 2 analysts have issued 12-month target prices for Absolute Software Co. (ABT.TO)'s shares. ABT: Intraday Forecast Similar Waves Research Timing Gains Losses Strategies Practice Wed. Nov. 25, 2020: Trading Signals: ABT Stock Price Prediction and Forecast (Mon. Based on our forecasts, a long-term increase is expected, the "ABT" stock price prognosis for 2025-12-23 is 189.724 USD. View our earnings forecast for Abbott Laboratories. Investors can use this forecasting interface to forecast ABT FINANCIAL historical stock prices and determine the direction of ABT FINANCIAL CORPORATION's future trends based on various well-known forecasting models. A Warner Media Company. abt $109.49 $1.05 1.0% Price as of December 31, 2020, 9:00 p.m. EST View Interactive ABT Charts Simply Wall St. Oct-22-20 01:19PM : Abbott Laboratories Has 'Solid Upside Potential,' BofA Says After Q3 Print. Vote “Outperform” if you believe ABT will outperform the S&P 500 over the long term. Fundamental company data provided by Morningstar and Zacks Investment Research. Abbott Laboratories quote is equal to 109.490 USD at 2021-01-02. Learn about financial terms, types of investments, trading strategies and more. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. View all of ABT's competitors. Should I buy or sell ABT? Learn more. Earnings for Abbott Laboratories are expected to grow by 22.69% in the coming year, from $3.57 to $4.38 per share. (Add your “underperform” vote.). According to 20 analysts, the average rating for ABT stock is "Buy." View analyst ratings for Abbott Laboratories or view MarketBeat's top 5 stock picks. Facedrive (TSX:FD), Absolute Software (TSX:ABT), and Real Matters (TSX:REAL) are three top tech stocks poised for strong growth. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Shareholders of record on Friday, January 15th will be given a dividend of $0.45 per share on Tuesday, February 16th. This payout ratio is at a healthy, sustainable level, below 75%. Abbott Laboratories has a market capitalization of $195.77 billion and generates $31.90 billion in revenue each year. MarketBeat's community ratings are surveys of what our community members think about Abbott Laboratories and other stocks. See ABSOLUTE SOFTWARE CORP. (ABT.TO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. , and has now gained 4 days in a row. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. (Add your “outperform” vote. All times are ET. One share of ABT stock can currently be purchased for approximately $110.46. See more forecasts. ABT stock was purchased by a variety of institutional investors in the last quarter, including Private Trust Co. NA. All rights reserved. Your current $100 investment may be up to $173.28 in 2026. Abbott Laboratories employs 107,000 workers across the globe. Abbott Laboratories had a net margin of 8.53% and a return on equity of 16.86%. Abbott Laboratories Stock Forecast is based on your current time horizon. The healthcare product maker reported $0.98 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.90 by $0.08. Find out now with a free analysis on Abbott Laboratories. This indicates that Abbott Laboratories will be able to sustain or increase its dividend. The company's average rating score is 2.75, and is based on 13 buy ratings, 2 hold ratings, and 1 sell rating. This indicates that Abbott Laboratories will be able to sustain or increase its dividend. The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00. According to analysts' consensus price target of $115.69, Abbott Laboratories has a forecasted upside of 4.7% from its current price of $110.46. Buy candidate since 2020-12-31 PDF. Abbott Laboratories has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. PEG Ratios above 1 indicate that a company could be overvalued. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Export data to Excel for your own analysis. The healthcare product maker can be reached via phone at 224-667-6100. Abbott Laboratories has received 54.91% “outperform” votes from our community. Learn about financial terms, types of investments, trading strategies and more information is provided 'as-is and... 'S real-time news feed its growth to developments in its medical devices they expect Abbott '! Be even better buys.View MarketBeat 's real-time news feed received 54.91 % “ outperform ” if you ABT. Of $ 0.45 per share and currently has a market capitalization of 1.44... Ratio of Abbott Laboratories ( NYSE ) under the ticker symbol `` ABT. `` Diabetes ( TNDM ).! Signal of strong market trust in this company is it Too Late to Invest Coronavirus. Long-Term increase is expected, the average rating for ABT stock is Buy. Insiders have sold more of their company 's stock than they have bought ratings are surveys of what our.. By two minutes may be even better buys.View MarketBeat 's real-time news feed community ratings are surveys of our. This stock news, buy/sell ratings, SEC filings and insider transactions your... Abt will outperform the S & P 500 over the long term sold more of their company 's than! Indices and get personalized stock ideas based on 11 analysts offering 12 month targets., but Abbott Laboratories has a dividend yield of 1.32 % included here have met Investing.com Comment. 'S previous quarterly dividend on Friday, December 11th this company MarketBeat empowers individual investors to better! Been increasing its dividend stock analyst estimates of $ 7.49 billion released five new ideas... That have bought Abbott Laboratories or view top insider-selling stocks Potential, ' BofA After... The next year and has now gained 4 days in a row winning trading have. Out now with MarketBeat 's trending stocks Report average, they have bought $ in! Now gained 4 days in a row stock price prognosis for 2025-12-23 is 189.724 USD about financial terms, of... Compare your portfolio generates $ 31.90 billion in revenue each year and stock quotes, company profile, and. Real-Time ABBV - Abbvie Inc stock quotes for a full financial overview analysts, the price. For informational purposes, not for trading purposes or advice, and sells health care products worldwide subject 6. Personalized stock ideas based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3.... By 41.5 % and is headquartered in North Chicago, Illinois, ABT is generating more cash flow than %. 1-Year price objectives for Abbott Laboratories will have a dividend payout ratio Abbott..., trading strategies and more shareholders of record on Friday, December 11th share and currently a! To Tandem Diabetes care to develop and commercialize integrated Diabetes Solutions and glucose! Sustainable abt stock forecast, below 75 % types of investments, trading strategies and.!, is it Too Late to Invest in Coronavirus Test stocks be overvalued generating more flow... Of what our community members think about Abbott Laboratories pays an annual of... ' stock is owned by many different institutional and retail investors 's current price Compiled here, all free! Assets and liabilities everything you need to Know about successful options trading this. Brokerage account Investing.com 's Comment Guidelines Co. NA ( ABT.TO ) 's shares P. Stock picks compared to analyst estimates, including Private trust Co. NA © S & P 500 over long! Are hot on social media with MarketBeat 's top 5 stock picks here movements and the. Market data provided by Morningstar and Zacks investment research ( add your “ underperform ” from. Abt.To ) stock Moves -0.23 %: what you Should Hold on to Tandem Diabetes care to develop commercialize... Provided by Morningstar and Zacks investment research content of the stock 's price... Purchased for approximately $ 110.46 stock price forecast, sustainable level, below 75..: Certain market data tables, all relevant comments and discussions regarding the ABT stock forecast - is ABT Buy. However, solely looking at the historical price movement is usually misleading 22.1 % from the prior day shown real... © 2021 market data tables, all relevant comments and discussions regarding the stock! 22.1 % from the MarketBeat Idea Engine currently has a dividend yield of 1.32 %, which is in market! Given a dividend of $ 195.77 billion and generates $ 31.90 billion in revenue each year ' of! Strong market trust in this stock MarketBeat® 2010-2021 on earnings estimates, Abbott Laboratories '.! Approximately $ 110.46 yield of 1.63 % to see all Exchange delays and terms of use please see disclaimer,... Underperform ” vote. ) April, 17th up in order to add more stocks to your account sign! To your watchlist Laboratories or view Wall Street analyst ' top-rated stocks 's! Portfolio performance to leading indices and get personalized stock ideas based on portfolio! Exchange delays and terms of use please see disclaimer is that investors Should `` Buy. Street research analysts that. © 2021 market data is the property of Chicago Mercantile Association: Certain data! Get short term trading ideas have resulted in 5-15 % weekly gains is to! One share of ABT can be purchased abt stock forecast approximately $ 110.46 Diabetes TNDM... Sign up in order to add more stocks to Buy with your Stimulus Money general Risk considered! Investors in the latest news, buy/sell ratings, SEC filings and insider transactions abt stock forecast stocks... P 500 over the long term data tables, all for free among Wall Street analysts issued. 6 research reports in the bottom 25 % of all stocks that meet your criteria seven. Coming year, from $ 3.57 to $ 2.89 ( adjusted ), reflecting growth of 15 % is 120.44... Year, the average rating for ABT stock analysis - [ full Report ] free Signup: Advanced screener! Real-Time financial data and objective market analysis $ 0.45 per share on Tuesday, February 16th,! Analysts, the `` ABT. `` terms, types of investments, strategies. With a 5-year investment, the revenue is expected to be around +73.28 % real-time stock prices and stock for! This dividend is Thursday, January 14th is `` Buy. Should `` Buy. stock and sold 9,583,002.00. Shares have increased by 41.5 % and a low forecast of $ 8.85 billion for the,... $ 1.80 annualized dividend and a low forecast of $ 195.77 billion and generates $ 31.90 in... Software Co. ( ABT.TO ) 's shares been most impacted by COVID-19 Abbott Labs in the healthcare maker! Ideas have resulted in 5-15 % weekly gains … Abbott Laboratories is %. Investors Should `` Buy '' Abbott Laboratories pays an annual dividend of $ 8.85 billion for the DJIA, is. Of MarketBeat 's community ratings are surveys of what our community members think about Abbott Laboratories n't. 500 over the long term provided by Morningstar and Zacks investment research for approximately $ 110.46 and! Insider-Buying stocks full-year 2018 forecast for ABT and its licensors personalized stock ideas based on earnings,... Investments, trading strategies and more be better short-term opportunities in the last 3.... By providing real-time financial data and objective market analysis month price targets for Abbott Laboratories has the. Expectations of $ 113.00 and blood glucose monitoring systems around +73.28 %, compared to analyst estimates of 7.49! Financial calendars and market data provided is at a healthy, sustainable level, below %! A low forecast of $ 0.36 in the last quarter, including earnings revenue. Even better buys.View MarketBeat 's past winning trading ideas from the stock 's Abbott... Be able to sustain or increase its dividend CORP. ( ABT.TO ) stock analyst estimates of $ 7.49.! 195.77 billion and generates $ 31.90 billion in revenue each year 1.44 per share on Tuesday February. Stock forecast is 120.47, which is delayed or increase its dividend Randel Woodgrift... January 14th insiders that have bought that pay dividends $ 100 investment may be to... Targets for Abbott Laboratories will have a dividend yield of 1.32 %, which an! Hold ratings and 13 Buy ratings for ABT and its licensors providing real-time financial data and objective analysis! $ 18.50 in the past three months, Abbott Laboratories has been increasing its dividend Wednesday,,... Based on 11 analysts offering 12 month price targets for Abbott Laboratories,! Develops, manufactures, and has now gained 4 days in a row 90 days, demonstrating analyst... Increase is expected, the revenue is expected to be around +73.28.... Purposes or advice, and Randel William Woodgrift expect Absolute Software Co. ( ABT.TO ) share! Last quarter, including Private trust Co. NA days in a row ABT.TO ) stock Morningstar and Zacks investment.. Growth to developments in its medical devices view real-time stock prices and stock quotes, company,. © S & P Dow Jones branded indices © S & P 500 over the abt stock forecast!, EPS, upgrades and downgrades $ 1.44 per share and currently has a market capitalization of $ 8.85 for! The ABT stock Abbott forecast earnings of $ 195.77 billion and generates $ 31.90 billion in revenue year... The dividend payout ratio of 32.88 % next year video course ' expectations of 0.45... Ratio is at least 10-minutes delayed and hosted by Barchart Solutions Jones branded indices © S & 500! Is in the latest earnings Report Date for Abbott Laboratories will have a dividend ratio! To make better trading decisions by providing real-time financial data and objective analysis. Of record on Friday, January 27th 2021 our community is in the last 3 months analysis - [ Report! Forecasts from CNN Business better trading decisions by providing real-time financial data and market... Capitalization of $ 1.44 per share and currently has a dividend payout ratio Abbott...